{
    "id": "dbpedia_856_0",
    "rank": 11,
    "data": {
        "url": "https://onlinecjc.ca/article/S0828-282X(22)00278-1/fulltext",
        "read_more_link": "",
        "language": "en",
        "title": "Surgical Strategies in Single Ventricle Management of Neonates and Infants",
        "top_image": "https://onlinecjc.ca/cms/asset/d5b9bcc1-3d97-4afd-8fb7-896f23a57917/gr3.jpg",
        "meta_img": "https://onlinecjc.ca/cms/asset/d5b9bcc1-3d97-4afd-8fb7-896f23a57917/gr3.jpg",
        "images": [
            "https://onlinecjc.ca/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif",
            "https://onlinecjc.ca/pb-assets/ux3/logos/ha/cjca-50pt-1650647311137.svg",
            "https://onlinecjc.ca/cms/asset/atypon:cms:attachment:img:d123e6:rev:1722647116564-7473:pii:S0828282X24X00082/cover.tif.jpg",
            "https://onlinecjc.ca/cms/asset/f1ab961d-3b9e-4e5a-9c2b-be1e77806975/cov200h.gif",
            "https://onlinecjc.ca/pb-assets/ux3/logos/ha/etoc/cjca_toc_banner-1656361928560.png",
            "https://onlinecjc.ca/templates/jsp/_style2/_marlin/images/bg_adVert.gif",
            "https://onlinecjc.ca/cms/10.1016/j.cjca.2022.04.021/asset/cb77620d-e42a-4025-9bff-bef95e8d610a/main.assets/gr1.sml",
            "https://onlinecjc.ca/cms/10.1016/j.cjca.2022.04.021/asset/79b6acb8-29ac-4cb3-9ad7-be23ac3d25bf/main.assets/gr2.sml",
            "https://onlinecjc.ca/cms/10.1016/j.cjca.2022.04.021/asset/ee127b09-25df-4d18-99c9-c8bba9c34c31/main.assets/gr3.sml",
            "https://onlinecjc.ca/cms/10.1016/j.cjca.2022.04.021/asset/1bd6c8eb-fdbc-4e27-918f-7fa972e5f67a/main.assets/gr4.sml",
            "https://onlinecjc.ca/cms/10.1016/j.cjca.2022.04.021/asset/7b53ac3d-2637-4331-919b-3e575c00be3f/main.assets/gr5.sml",
            "https://onlinecjc.ca/cms/10.1016/j.cjca.2022.04.021/asset/c76ac210-3f0f-49c6-9c61-f9046bbf73d5/main.assets/gr6.sml",
            "https://onlinecjc.ca/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png",
            "https://onlinecjc.ca/cms/asset/1c5b881a-f58a-4ec7-b876-9507b706a010/cov150h.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Christoph Haller",
            "David J. Barron",
            "this author"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "No area of congenital heart disease has undergone greater change and innovation than\nsingle ventricle management over the past 20 years. Surgical and catheterisation laboratory\ninterventions have transformed outcomes such that in some subgroups more than 80%\nof the patients can survive into adulthood. Driven by parallel development in diagnostic\nimaging and cardiac intensive care, surgical management is focused on the neonatal\nperiod as the key time to creating a balanced circulation and limiting pulmonary blood\nflow.",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "Canadian Journal of Cardiology",
        "canonical_link": "https://onlinecjc.ca/article/S0828-282X(22)00278-1/abstract",
        "text": "Department of Cardiovascular Surgery, Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada\n\nPublication History:\n\nReceived February 15, 2022; Accepted April 26, 2022; Published online May 2, 2022\n\nCopyright: Crown Copyright © 2022 Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society. All rights reserved.\n\nDownload started\n\nOk\n\nDownload started\n\nOk\n\nAbstract\n\nAbstract\n\nNo area of congenital heart disease has undergone greater change and innovation than single ventricle management over the past 20 years. Surgical and catheterisation laboratory interventions have transformed outcomes such that in some subgroups more than 80% of the patients can survive into adulthood. Driven by parallel development in diagnostic imaging and cardiac intensive care, surgical management is focused on the neonatal period as the key time to creating a balanced circulation and limiting pulmonary blood flow. Different configurations of the circulation, including new types of surgical shunts, and the role of “hybrid” circulations provide greater options and better physiology. This overview focuses on these changes in surgical management and timing, but also looks at the exciting areas of regenerative therapies to improve ventricular function, and the concept of ventricular rehabilitation to achieve biventricular circulations in certain groups of patients. The importance of early (neonatal) intervention and multidisciplinary approach to management is emphasised, as well as looking beyond simply survival to also improving neurodevelopmental outcomes.\n\nRésumé\n\nLa prise en charge du cœur univentriculaire a été marquée par les changements et les innovations les plus marquants dans le domaine des cardiopathies congénitales au cours des vingt dernières années. Les interventions chirurgicales et le cathétérisme en laboratoire ont connu de telles avancées que, dans certains sous-groupes, plus de 80 % des patients survivent jusqu’à l’âge adulte. Grâce au développement parallèle de l’imagerie diagnostique et des soins intensifs cardiaques, la prise en charge chirurgicale se focalise sur la période néonatale comme moment clé pour établir une circulation équilibrée et limiter le flux sanguin pulmonaire. Différentes configurations circulatoires, notamment de nouveaux types de shunts chirurgicaux et les circulations « hybrides », multiplient les options envisageables et se traduisent par des gains sur le plan physiologique. Le présent article de synthèse est centré sur ces changements touchant la prise en charge chirurgicale et le moment de sa mise en œuvre. Nous y abordons par ailleurs le domaine passionnant des thérapies régénératives ayant pour but d’améliorer la fonction ventriculaire, de même que le concept de la réadaptation ventriculaire visant à établir des circulations biventriculaires chez certains patients. Nous soulignons aussi l’importance d’une intervention précoce (néonatale) et d’une prise en charge multidisciplinaire pour non seulement prolonger la survie, mais aussi améliorer les résultats sur le plan neurodéveloppemental.\n\nGet full text access\n\nLog in, subscribe or purchase for full access.\n\nReferences\n\n1.\n\nMascio, C.E. ∙ Irons, M.L. ∙ Ittenbach, R.F. ...\n\nThirty years and 1663 consecutive Norwood procedures: has survival plateaued?\n\nJ Thorac Cardiovasc Surg. 2019; 158:220-229\n\n2.\n\nHadjicosta, E. ∙ Franklin, R. ∙ Seale, A. ...\n\nCohort study of intervened functionally univentricular heart in England and Wales (2000-2018)\n\nHeart. 2022; 108:1046-1054\n\n3.\n\nSiffel, C. ∙ Riehle-Colarusso, T. ∙ Oster, M.E. ...\n\nSurvival of children with hypoplastic left heart syndrome\n\nPediatrics. 2015; 136:e864-e870\n\n4.\n\nBest, K.E. ∙ Miller, N. ∙ Draper, E. ...\n\nThe improved prognosis of hypoplastic left heart: a population-based register study of 343 cases in England and Wales\n\nFront Pediatr. 2021; 9:635776\n\n5.\n\nSavla, J.J. ∙ Putt, M.E. ∙ Huang, J. ...\n\nImpact of maternal-fetal environment on mortality in children with single ventricle heart disease\n\nJ Am Heart Assoc. 2022; 11, e020299\n\n6.\n\nFreud, L.R. ∙ Seed, M.\n\nPrenatal diagnosis and management of single ventricle heart disease\n\nCan J Cardiol. 2022; 38:897-908\n\n7.\n\nCloete, E. ∙ Bloomfield, F.H. ∙ Sadler, L. ...\n\nAntenatal detection of treatable critical congenital heart disease is associated with lower morbidity and mortality\n\nJ Pediatr. 2019; 204:66-70\n\n8.\n\nRasiah, S.V. ∙ Ewer, A.K. ∙ Miller, P. ...\n\nAntenatal perspective of hypoplastic left heart syndrome: 5 years on\n\nArch Dis Child Fetal Neonatal Ed. 2008; 93:F192-F197\n\n9.\n\nMurtuza, B. ∙ Jones, T.J. ∙ Barron, D.J. ...\n\nTemporary restriction of right ventricle-pulmonary artery conduit flow using haemostatic clips following Norwood I reconstruction: potential for improved outcomes\n\nInteract Cardiovasc Thorac Surg. 2012; 14:327-329\n\n10.\n\nHoffman, G.M. ∙ Tweddell, J.S. ∙ Ghanayem, N.S. ...\n\nAlteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the norwood procedure\n\nJ Thorac Cardiovasc Surg. 2004; 127:738-745\n\n11.\n\nIsmail, M.F. ∙ Elmahrouk, A.F. ∙ Arafat, A.A. ...\n\nEvolution of the Norwood operation outcomes in patients with late presentation\n\nJ Thorac Cardiovasc Surg. 2020; 159:1040-1048\n\n12.\n\nElmahrouk, A.F. ∙ Ismail, M.F. ∙ Arafat, A.A. ...\n\nCombined Norwood and cavopulmonary shunt as the first palliation in late presenters with hypoplastic left heart syndrome and single ventricle lesions.\n\nJ Thorac Cardiovasc Surg. 2022; 163:1592-1600\n\n13.\n\nSames-Dolzer, E. ∙ Hakami, L. ∙ Innerhuber, M. ...\n\nOlder age at the time of the Norwood procedure is a risk factor for early postoperative mortality\n\nEur J Cardiothorac Surg. 2015; 47:257-261\n\n14.\n\nFrommelt, P.C. ∙ Guey, L.T. ∙ Minich, L.L. ...\n\nDoes initial shunt type for the norwood procedure affect echocardiographic measures of cardiac size and function during infancy? The Single Ventricle Reconstruction Trial\n\nCirculation. 2012; 125:2630-2638\n\n15.\n\nNewburger, J.W. ∙ Sleeper, L.A. ∙ Gaynor, J.W. ...\n\nTransplant-free survival and interventions at 6 years in the SVR Trial\n\nCirculation. 2018; 137:2246-2253\n\n16.\n\nFrommelt, P.C. ∙ Hu, C. ∙ Trachtenberg, F. ...\n\nImpact of initial shunt type on echocardiographic indices in children after single right ventricle palliations: the SVR Trial at 6 years\n\nCirc Cardiovasc Imaging. 2019; 12\n\n17.\n\nMahle, W.T. ∙ Hu, C. ∙ Trachtenberg, F. ...\n\nHeart failure after the Norwood procedure: an analysis of the Single Ventricle Reconstruction Trial\n\nJ Heart Lung Transplant. 2018; 37:879-885\n\n18.\n\nWilder, T.J. ∙ McCrindle, B.W. ∙ Phillips, A.B. ...\n\nSurvival and right ventricular performance for matched children after stage-1 Norwood: modified Blalock-Taussig shunt versus right-ventricle–to–pulmonary-artery conduit\n\nJ Thorac Cardiovasc Surg. 2015; 150 1440-52.e8.\n\n19.\n\nTseng, S.Y. ∙ Siddiqui, S. ∙ Di Maria, M.V. ...\n\nAtrioventricular valve regurgitation in single ventricle heart disease: a common problem associated with progressive deterioration and mortality\n\nJ Am Heart Assoc. 2020; 9\n\n20.\n\nMahle, W.T. ∙ Cohen, M.S. ∙ Spray, T.L. ...\n\nAtrioventricular valve regurgitation in patients with single ventricle: impact of the bidirectional cavopulmonary anastomosis\n\nAnn Thorac Surg. 2001; 72:831-835\n\n21.\n\nHonjo, O. ∙ Atlin, C.R. ∙ Mertens, L. ...\n\nAtrioventricular valve repair in patients with functional single-ventricle physiology: Impact of ventricular and valve function and morphology on survival and reintervention\n\nJ Thorac Cardiovasc Surg. 2011; 142 326-35.e2\n\n22.\n\nHill, K.D. ∙ Rhodes, J.F. ∙ Aiyagari, R. ...\n\nIntervention for recoarctation in the Single Ventricle Reconstruction Trial: incidence, risk, and outcomes\n\nCirculation. 2013; 128:954-961\n\n23.\n\nHaller, C. ∙ Chetan, D. ∙ Saedi, A. ...\n\nGeometry and growth of the reconstructed aorta in patients with hypoplastic left heart syndrome and variants\n\nJ Thorac Cardiovasc Surg. 2017; 153:1479-14787.e1\n\n24.\n\nKumar, S.R. ∙ Kung, G. ∙ Noh, N. ...\n\nSingle-ventricle outcomes after neonatal palliation of severe Ebstein anomaly with modified Starnes procedure\n\nCirculation. 2016; 134:1257-1264\n\n25.\n\nBentham, J.R. ∙ Zava, N.K. ∙ Harrison, W.J. ...\n\nDuct stenting versus modified Blalock-Taussig shunt in neonates with duct-dependent pulmonary blood flow: associations with clinical outcomes in a multicenter national study\n\nCirculation. 2018; 137:581-588\n\n26.\n\nGlatz, A.C. ∙ Petit, C.J. ∙ Goldstein, B.H. ...\n\nComparison between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the Congenital Catheterisation Research Collaborative\n\nCirculation. 2018; 137:589-601\n\n27.\n\nAlsagheir, A. ∙ Koziarz, A. ∙ Makhdoum, A. ...\n\nDuct stenting versus modified Blalock-Taussig shunt in neonates and infants with duct-dependent pulmonary blood flow: a systematic review and meta-analysis\n\nJ Thorac Cardiovasc Surg. 2021; 161:379-390.e8\n\n28.\n\nHaller, C. ∙ Caldarone, C.A.\n\nThe evolution of therapeutic strategies: niche apportionment for hybrid palliation\n\nAnn Thorac Surg. 2018; 106:1873-1880\n\n29.\n\nChetan, D. ∙ Kotani, Y. ∙ Jacques, F. ...\n\nSurgical palliation strategy does not affect interstage ventricular dysfunction or atrioventricular valve regurgitation in children with hypoplastic left heart syndrome and variants\n\nCirculation. 2013; 128:S205-S212\n\n30.\n\nGrotenhuis, H.B. ∙ Ruijsink, B. ∙ Chetan, D. ...\n\nImpact of Norwood versus hybrid palliation on cardiac size and function in hypoplastic left heart syndrome\n\nHeart. 2016; 102:966-974\n\n31.\n\nWilder, T.J. ∙ McCrindle, B.W. ∙ Hickey, E.J. ...\n\nIs a hybrid strategy a lower-risk alternative to stage 1 Norwood operation?\n\nJ Thorac Cardiovasc Surg. 2017; 153:163-172.e6\n\n32.\n\nShimizu, S. ∙ Kawada, T. ∙ Une, D. ...\n\nHybrid stage I palliation for hypoplastic left heart syndrome has no advantage on ventricular energetics: a theoretical analysis\n\nHeart Vessels. 2016; 31:105-113\n\n33.\n\nLi, J. ∙ Zhang, G. ∙ Benson, L. ...\n\nComparison of the profiles of postoperative systemic hemodynamics and oxygen transport in neonates after the hybrid or the Norwood procedure: a pilot study\n\nCirculation. 2007; 116 I-179-87\n\n34.\n\nKobayashi, D. ∙ Natarajan, G. ∙ Turner, D.R. ...\n\nEffect of hybrid stage 1 procedure on ventricular function in infants with hypoplastic left heart syndrome\n\nCardiol Young. 2016; 26:867-875\n\n35.\n\nLatus, H. ∙ Nassar, M.S. ∙ Wong, J. ...\n\nVentricular function and vascular dimensions after Norwood and hybrid palliation of hypoplastic left heart syndrome\n\nHeart. 2018; 104:244-252\n\n36.\n\ndi Molfetta, A. ∙ Iacobelli, R. ∙ Guccione, P. ...\n\nEvolution of ventricular energetics in the different stages of palliation of hypoplastic left heart syndrome: a retrospective clinical study\n\nPediatr Cardiol. 2017; 38:1613-1619\n\n37.\n\nGaber, N. ∙ Gagliardi, M. ∙ Patel, P. ...\n\nFetal reprogramming and senescence in hypoplastic left heart syndrome and in human pluripotent stem cells during cardiac differentiation\n\nAm J Pathol. 2013; 183:720-734\n\n38.\n\nBrooks, P.A. ∙ Khoo, N.S. ∙ Mackie, A.S. ...\n\nRight ventricular function in fetal hypoplastic left heart syndrome\n\nJ Am Soc Echocardiogr. 2012; 25:1068-1074\n\n39.\n\nBrooks, P.A. ∙ Khoo, N.S. ∙ Hornberger, L.K.\n\nSystolic and diastolic function of the fetal single left ventricle\n\nJ Am Soc Echocardiogr. 2014; 27:972-977\n\n40.\n\nTraister, A. ∙ Patel, R. ∙ Huang, A. ...\n\nCardiac regenerative capacity is age- and disease-dependent in childhood heart disease\n\nPLoS One. 2018; 13, e0200342\n\n41.\n\nTworetzky, W. ∙ Wilkins-Haug, L. ∙ Jennings, R.W. ...\n\nBalloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention\n\nCirculation. 2004; 110:2125-2131\n\n42.\n\nFreud, L.R. ∙ McElhinney, D.B. ∙ Marshall, A.C. ...\n\nFetal aortic valvuloplasty for evolving hypoplastic left heart syndrome\n\nCirculation. 2014; 130:638-645\n\n43.\n\nHogan, W.J. ∙ Grinenco, S. ∙ Armstrong, A. ...\n\nFetal cardiac intervention for pulmonary atresia with intact ventricular septum: International Fetal Cardiac Intervention Registry\n\nFetal Diagn Ther. 2020; 47:731-739\n\n44.\n\nChaturvedi, R.R. ∙ Ryan, G. ∙ Seed, M. ...\n\nFetal stenting of the atrial septum: Technique and initial results in cardiac lesions with left atrial hypertension\n\nInt J Cardiol. 2013; 168:2029-2036\n\n45.\n\nMeza, J.M. ∙ Jaquiss, R.D.B. ∙ Anderson, B.R. ...\n\nCurrent practices in the timing of stage 2 palliation: a survey of the CHSS and ECHSA\n\nWorld J Pediatr Congenit Heart Surg. 2017; 8:135-141\n\n46.\n\nMeza, J.M. ∙ Hickey, E.J. ∙ Blackstone, E.H. ...\n\nThe optimal timing of stage 2 palliation for hypoplastic left heart syndrome: an analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial public data set\n\nCirculation. 2017; 136:1737-1748\n\n47.\n\nMeza, J.M. ∙ Hickey, E. ∙ McCrindle, B. ...\n\nThe optimal timing of stage-2-palliation after the Norwood operation\n\nAnn Thorac Surg. 2018; 105:193-199\n\n48.\n\nBarron, D.J. ∙ Haq, I.U. ∙ Crucean, A. ...\n\nThe importance of age and weight on cavopulmonary shunt (stage II) outcomes after the Norwood procedure: planned versus unplanned surgery\n\nJ Thorac Cardiovasc Surg. 2017; 154:228-238\n\n49.\n\nRüffer, A. ∙ Arndt, F. ∙ Potapov, S. ...\n\nEarly stage 2 palliation is crucial in patients with a right-ventricle–to–pulmonary-artery conduit\n\nAnn Thorac Surg. 2011; 91:816-822\n\n50.\n\nRudd, N.A. ∙ Ghanayem, N.S. ∙ Hill, G.D. ...\n\nInterstage home monitoring for infants with single ventricle heart disease: education and management: a scientific statement from the American Heart Association\n\nJ Am Heart Assoc. 2020; 9, e014548\n\n51.\n\nPoh, C.L. ∙ Chiletti, R. ∙ Zannino, D. ...\n\nVentricular assist device support in patients with single ventricles: the Melbourne experience\n\nInteract Cardiovasc Thorac Surg. 2017; 25:310-316\n\n52.\n\nHickey, E. ∙ Pham-Hung, E. ∙ Nosikova, Y. ...\n\nNASA model of “threat and error” in pediatric cardiac surgery: patterns of error chains\n\nAnn Thorac Surg. 2017; 103:1300-1307\n\n53.\n\nRuiz, V.M. ∙ Saenz, L. ∙ Lopez-Magallon, A. ...\n\nEarly prediction of critical events for infants with single-ventricle physiology in critical care using routinely collected data\n\nJ Thorac Cardiovasc Surg. 2019; 158:234-243.e3\n\n54.\n\nHoffman, G.M. ∙ Niebler, R.A. ∙ Scott, J.P. ...\n\nInterventions associated with treatment of low cardiac output after stage 1 Norwood palliation\n\nAnn Thorac Surg. 2021; 111:1620-1627\n\n55.\n\nHaller, C. ∙ Friedberg, M.K. ∙ Laflamme, M.A.\n\nThe role of regenerative therapy in the treatment of right ventricular failure: a literature review\n\nStem Cell Res Ther. 2020; 11:502\n\n56.\n\nWehman, B. ∙ Sharma, S. ∙ Pietris, N. ...\n\nMesenchymal stem cells preserve neonatal right ventricular function in a porcine model of pressure overload\n\nAm J Physiol-Heart Circ Physiol. 2016; 310:H1816-H1826\n\n57.\n\nLiufu, R. ∙ Shi, G. ∙ He, X. ...\n\nThe therapeutic impact of human neonatal BMSC in a right ventricular pressure overload model in mice\n\nStem Cell Res Ther. 2020; 11:96\n\n58.\n\nOommen, S. ∙ Yamada, S. ∙ Cantero Peral, S. ...\n\nHuman umbilical cord blood–derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload\n\nStem Cell Res Ther. 2015; 6:50\n\n59.\n\nDavies, B. ∙ Elwood, N.J. ∙ Li, S. ...\n\nHuman cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training\n\nAnn Thorac Surg. 2010; 89:585-593.e4\n\n60.\n\nSano, T. ∙ Ousaka, D. ∙ Goto, T. ...\n\nImpact of cardiac progenitor cells on heart failure and survival in single ventricle congenital heart disease\n\nCirc Res. 2018; 122:994-1005\n\n61.\n\nWehman, B. ∙ Pietris, N. ∙ Bigham, G. ...\n\nCardiac progenitor cells enhance neonatal right ventricular function after pulmonary artery banding\n\nAnn Thorac Surg. 2017; 104:2045-2053\n\n62.\n\nSharma, S. ∙ Mishra, R. ∙ Bigham, G.E. ...\n\nA deep proteome analysis identifies the complete secretome as the functional unit of human cardiac progenitor cells\n\nCirc Res. 2017; 120:816-834\n\n63.\n\nNie, S. ∙ Wang, X. ∙ Sivakumaran, P. ...\n\nBiologically active constituents of the secretome of human W8B2+ cardiac stem cells\n\nSci Rep. 2018; 8:1579\n\n64.\n\nWeixler, V. ∙ Lapusca, R. ∙ Grangl, G. ...\n\nAutogenous mitochondria transplantation for treatment of right heart failure\n\nJ Thorac Cardiovasc Surg. 2021; 162:e111-e121\n\n65.\n\nRupp, S. ∙ Bauer, J. ∙ Tonn, T. ...\n\nIntracoronary administration of autologous bone marrow–derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy\n\nPediatr Transplant. 2009; 13:620-623\n\n66.\n\nRupp, S. ∙ Zeiher, A.M. ∙ Dimmeler, S. ...\n\nA regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow–derived progenitor cells\n\nJ Heart Lung Transplant. 2010; 29:574-577\n\n67.\n\nRupp, S. ∙ Jux, C. ∙ Bönig, H. ...\n\nIntracoronary bone marrow cell application for terminal heart failure in children\n\nCardiol Young. 2012; 22:558-563\n\n68.\n\nBurkhart, H.M. ∙ Qureshi, M.Y. ∙ Rossano, J.W. ...\n\nAutologous stem cell therapy for hypoplastic left heart syndrome: safety and feasibility of intraoperative intramyocardial injections\n\nJ Thorac Cardiovasc Surg. 2019; 158:1614-1623\n\n69.\n\nVincenti, M. ∙ O’Leary, P.W. ∙ Qureshi, M.Y. ...\n\nClinical impact of autologous cell therapy on hypoplastic left heart syndrome after bidirectional cavopulmonary anastomosis\n\nSemin Thorac Cardiovasc Surg. 2021; 33:791-801\n\n70.\n\nKaushal, S. ∙ Wehman, B. ∙ Pietris, N. ...\n\nStudy design and rationale for ELPIS: A phase I/IIb randomised pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome\n\nAm Heart J. 2017; 192:48-56\n\n71.\n\nIshigami, S. ∙ Ohtsuki, S. ∙ Tarui, S. ...\n\nIntracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial\n\nCirc Res. 2015; 116:653-664\n\n72.\n\nIshigami, S. ∙ Ohtsuki, S. ∙ Eitoku, T. ...\n\nIntracoronary cardiac progenitor cells in single ventricle physiology: the PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) randomised phase 2 trial\n\nCirc Res. 2017; 120:1162-1173\n\n73.\n\nShiba, Y. ∙ Fernandes, S. ∙ Zhu, W.Z. ...\n\nHuman ES-cell–derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts\n\nNature. 2012; 489:322-325\n\n74.\n\nShiba, Y. ∙ Filice, D. ∙ Fernandes, S. ...\n\nElectrical integration of human embryonic stem cell–derived cardiomyocytes in a guinea pig chronic infarct model\n\nJ Cardiovasc Pharmacol Ther. 2014; 19:368-381\n\n75.\n\nRomagnuolo, R. ∙ Masoudpour, H. ∙ Porta-Sánchez, A. ...\n\nHuman embryonic stem cell–derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias\n\nStem Cell Rep. 2019; 12:967-981\n\n76.\n\nFilice, D. ∙ Dhahri, W. ∙ Solan, J.L. ...\n\nOptical mapping of human embryonic stem cell–derived cardiomyocyte graft electrical activity in injured hearts\n\nStem Cell Res Ther. 2020; 11:417\n\n77.\n\nYerebakan, C. ∙ Murray, J. ∙ Valeske, K. ...\n\nLong-term results of biventricular repair after initial Giessen hybrid approach for hypoplastic left heart variants\n\nJ Thorac Cardiovasc Surg. 2015; 149 1112-22.e2\n\n78.\n\nHaller, C. ∙ Honjo, O. ∙ Caldarone, C.A. ...\n\nGrowing the borderline hypoplastic left ventricle: hybrid approach\n\nOper Tech Thorac Cardiovasc Surg. 2016; 21:124-138\n\n79.\n\nSojak, V. ∙ Bokenkamp, R. ∙ Kuipers, I. ...\n\nBiventricular repair after the hybrid Norwood procedure\n\nEur J Cardiothorac Surg. 2019; 56:110-116\n\n80.\n\nHickey, E.J. ∙ Caldarone, C.A. ∙ Blackstone, E.H. ...\n\nCritical left ventricular outflow tract obstruction: the disproportionate impact of biventricular repair in borderline cases\n\nJ Thorac Cardiovasc Surg. 2007; 134:1429-1437.e7\n\n81.\n\nEmani, S.M.\n\nBiventricular repair in patients with borderline left heart—the “growing” experience\n\nWorld J Pediatr Congenit Heart Surg. 2019; 10:18-19\n\n82.\n\nVerrall, C.E. ∙ Yang, J.Y.M. ∙ Chen, J. ...\n\nNeurocognitive dysfunction and smaller brain volumes in adolescents and adults with a Fontan circulation\n\nCirculation. 2021; 143:878-891\n\n83.\n\ndu Plessis, K. ∙ d’Udekem, Y.\n\nThe neurodevelopmental outcomes of patients with single ventricles across the lifespan\n\nAnn Thorac Surg. 2019; 108:1565-1572\n\n84.\n\nPeyvandi, S. ∙ Lim, J.M. ∙ Marini, D. ...\n\nFetal brain growth and risk of postnatal white matter injury in critical congenital heart disease\n\nJ Thorac Cardiovasc Surg. 2021; 162 1007-10014.e1\n\n85.\n\nSarajuuri, A. ∙ Jokinen, E. ∙ Puosi, R. ...\n\nNeurodevelopment in children with hypoplastic left heart syndrome\n\nJ Pediatr. 2010; 157 414-20.e4\n\n86.\n\nRotermann, I. ∙ Logoteta, J. ∙ Falta, J. ...\n\nNeurodevelopmental outcome in single-ventricle patients: is the Norwood procedure a risk factor?\n\nEur J Cardiothorac Surg. 2017; 52:558-564\n\n87.\n\nBergmane, I. ∙ Lacis, A. ∙ Lubaua, I. ...\n\nFollow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy\n\nPediatr Transplant. 2013; 17:266-270\n\n88.\n\nBarron, D.J. ∙ Kilby, M.D. ∙ Davies, B. ...\n\nHypoplastic left heart syndrome. 2009; 374:14\n\n89.\n\nEmani, S.M. ∙ Bacha, E.A. ∙ McElhinney, D.B. ...\n\nPrimary left ventricular rehabilitation is effective in maintaining two-ventricle physiology in the borderline left heart\n\nJ Thorac Cardiovasc Surg. 2009; 138:1276-1282\n\nArticle metrics\n\nChristoph Haller, MD\n\nAffiliations\n\nDepartment of Cardiovascular Surgery, Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada\n\nDavid J. Barron, MD\n\nCorrespondence\n\nCorresponding author: Dr David J. Barron, Division of Cardiovascular Surgery, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada. Tel.: +1-416-813-6420; fax: +1-416-813-7984.\n\nAffiliations\n\nDepartment of Cardiovascular Surgery, Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada\n\nOpen in viewer"
    }
}